Updated Jan 16, 2018

Default inno

PPAR-gamma agonists for the treatment of cerebral malaria – tweaking the host response to save brains

http://www.uhn.ca/

The innovation has no owner

CLAIM IT

Stage 1 : Ideation

Registered in Canada.

Focus Areas:

Health and Infectious & Vector Diseases

Health and Infectious & Vector DiseasesSEE LESS

Implemented In:

Cambodia

CambodiaSEE LESS

1
Country Implemented In
Verified Funding
?

Innovation Description

This project aims to rescue a child with cerebral malaria by using PPARg agonists, a type of anti-diabetic drug.
How does your innovation work?
This project aims to rescue a child with cerebral malaria from death or long-term cognitive impairment, by protecting their brain. The idea is to use PPARg agonists, a type of anti-diabetic drug, to treat cerebral malaria. PPARg agonists have neuro-protective and neuro-regenerative properties, that may help to reduce and repair malaria-caused brain injury.

Milestones

Date Unknown
Created
Date Unknown
New Country Implemented In
Cambodia